Roger Adsett - Mar 8, 2022 Form 4 Insider Report for Landos Biopharma, Inc. (LABP)

Role
Director
Signature
/s/ Eric W. Blanchard, attorney-in-fact
Stock symbol
LABP
Transactions as of
Mar 8, 2022
Transactions value $
$0
Form type
4
Date filed
3/10/2022, 03:19 PM
Previous filing
Jan 13, 2022
Next filing
May 13, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LABP Stock Option (right to buy) Award $0 +36K $0.00 36K Mar 8, 2022 Common Stock 36K $1.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying this option will vest and become exercisable in 36 equal monthly installments beginning on March 8, 2022, subject to the Reporting Person's continuous service with the Issuer on each such date.